Skin Analytics

We are building a future where no one dies from skin cancer

Neil Daly, Founder and CEO
Founder
Neil Daly
When we invested
Series A
Founded
2012
Partnered
2020
Location
UK
Area
Digital health

What we do

We enable GPs to conduct dermatologist quality skin cancer assessments within seconds whilst reducing their referral volumes.

For Hospitals, we’re able to design new pathways that are 40% more efficient and reduce demand on the scarce dermatology resource.

We build innovative skin cancer pathways that leverage our clinically validated AI to diagnose more skin cancer

  1. Clinically validated AI both for efficacy and health economic benefit.
  2. Regulatory clearance in Europe and FDA Breakthrough Device designation.
  3. Proven in the real world with NHS and private health providers.

We are
evolving

We're at the start of an exciting new chapter to shape the future of healthcare in new ways. Come back soon to visit our new website for details, or visit our current website in the meantime.

We are evolving, new site coming soon...